AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Final approval has been granted (January 29, 2007) for first-time generic dexmethylphenidate, manufactured by Teva Pharma, to treat attention-deficit/hyperactivity disorder in children and adults. The Reference Listed Drug is Focalin Tablets. [www.fda.gov/cder]
The FDA has granted marketing approval (February 23, 2007) for a first and only stimulant prodrug …